FDA Approval of Heron Therapeutics' (HRTX) Sustol Removes Major Overhang - Analyst
Go back to FDA Approval of Heron Therapeutics' (HRTX) Sustol Removes Major Overhang - Analyst| HERON THERAPEUTICS (NASDAQ: HRTX) | Delayed: 2.65 -0.15 (5.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.80 | 52 Week High | $31.32 | |||
| Open | $2.82 | 52 Week Low | $13.95 | |||
| Day High | $2.86 | P/E | N/A | |||
| Day Low | $2.64 | EPS | $-3.29 | |||
| Volume | 2,169,494 | |||||
